Ms.Federer is an investor, board member for public and private companies, and a globally recognized leader in digital transformation, health technologies, and women's health. She is the Managing Director of the Women's Health Fund. Previously, she was the Chief Digital Officer for Bayer, leading the enterprise-wide digital transformation across the Pharmaceutical, Consumer Care, Crop Science, and Animal Health businesses. She was the first woman to hold this role in the pharma industry globally. She is an external senior advisor for McKinsey and has advised both Fortune Global 100 companies and industry disrupting start-ups. During the pandemic, she joined Europe’s fastest growing digital health company as Managing Director, building a U.S. team and expanding into decentralized clinical trials for international Covid-19 vaccine studies. Federer also serves on the board of Angelini Ventures, a Rome-based fund investing in biotech and digital health, and was previously a partner at an established Boston-based VC. She founded the Health of Women Investor Summit, convening investors representing trillions in investment capital, and serves on both the Yale Ventures Blavatnik Advisor board and the Yale Institutional Review Board. Federer was on the United Nations International Telecommunications Union m-powering development advisory board and the BHP Science and Innovation Advisory Council.